The global market for endoscopic procedures is projected to grow significantly, reaching approximately US$ 53,196.65 million by 2030, up from US$ 30,877.37 million in 2022. This growth represents a compound annual growth rate (CAGR) of 7.0% from 2022 to 2030.
Several factors are contributing to this market expansion, including an increasing preference for minimally invasive surgical techniques and a rise in the incidence of chronic illnesses. Nevertheless, the potential for infections associated with endoscopic procedures poses a challenge to market growth.
Technological Innovations Creating New Opportunities in the Endoscopy Procedure Market
In North America, the endoscopy sector has experienced numerous technological innovations and product introductions. These advancements are anticipated to enhance diagnostic accuracy and improve the safety of endoscopic procedures. Below are some notable recent developments:
In April 2021, Olympus expanded its U.S. bronchoscopy offerings with the introduction of the H-SteriScope Single-Use Bronchoscopes, which received 510(k) clearance. This new line includes five premium endoscopes designed for advanced diagnostic and therapeutic applications. The H-SteriScope portfolio was developed in collaboration with Veran Medical Technologies, Inc., a subsidiary of Olympus, and Hunan Vathin Medical Instrument Co., Ltd.
Also in April 2021, Ambu Inc. secured Health Canada approval for its aScope 4 Cysto, a novel flexible cystoscope platform tailored for urological applications. This cost-effective, high-quality flexible endoscope boasts superior maneuverability and optics. Unlike traditional reusable endoscopes, the single-use design eliminates substantial costs associated with capital, repairs, and cleaning, ensuring that each instrument is sterile and ready for immediate use, thereby enhancing workflow efficiency.
In December 2021, Medtronic Canada ULC, a subsidiary of Medtronic plc, obtained a Health Canada license for the Hugo robotic-assisted surgery (RAS) system, which is applicable for urological and gynecological laparoscopic surgeries?accounting for nearly half of all robotic procedures in Canada. This modular platform features wristed instruments, 3D visualization, and a cloud-based surgical video capture option, along with dedicated support for optimizing robotics programs.
In November 2022, PENTAX Medical introduced the Performance Endoscopic Ultrasound (EUS) system in Canada, which combines the ARIETTA 65 PX ultrasound scanner with the J10 Series Ultrasound Gastroscopes. This system is designed for endoscopic ultrasound practitioners focused on productivity, delivering high-quality imaging and efficiency for managing large case volumes.
On April 12, 2021, Cosmo Pharmaceuticals NV announced the FDA's approval of the GI Genius intelligent endoscopy system, a groundbreaking device for real-time lesion detection during colonoscopy. This system is the first of its kind to receive FDA approval via the De Novo pathway and is designed to assist endoscopists in identifying lesions easily, being compatible with all endoscopes.
In December 2019, Boston Scientific Corporation launched the "EXALT Model D," the world?s first single-use duodenoscope for endoscopic retrograde cholangiopancreatography (ERCP) procedures. This third-generation device incorporates design enhancements based on physician feedback to improve user experience.
These advancements are expected to create significant growth opportunities for the endoscopy procedure market in the coming years.
Insights Based on Procedures
The endoscopy procedures market is categorized by various procedures, including endoscopic retrograde cholangiopancreatography (ERCP), endoscopic submucosal dissection (ESD), peroral endoscopic myotomy (POEM), endoscopic ultrasound (EUS), interventional pulmonology, laparoscopy, arthroscopy, bronchoscopy, colonoscopy, colposcopy, proctoscopy, thoracoscopy, and others. In 2022, the arthroscopy and bronchoscopy segment dominated the market. However, the ERCP segment is anticipated to experience the fastest growth during the forecast period.
Insights Based on Offerings
The endoscopy procedures market is segmented by offerings, which include endoscopes, ERCP accessories, visualization systems, head positioners, endotherapy injection needles, sampling devices, device clips, electrosurgical knives, endoscopic ultrasound guided devices, guidewires, forceps, snares, irrigation/insufflation tubing systems, probes, hemostatic clips, polyp traps, single-use valves, trocar sleeves, tissue scissors and cutters, retrieval devices, and others. In 2022, the endoscopes segment held the largest market share, while the ERCP accessories segment is projected to grow at the highest rate during the forecast period.
Insights Based on Product Types
The endoscopy procedures market is divided into disposable and reusable product types. The reusable segment accounted for the largest market share in 2022, while the disposable segment is expected to witness the highest CAGR during the forecast period.
Insights Based on End Users
The endoscopy procedures market is categorized by end users, including hospitals and clinics, ambulatory surgical centers, diagnostic laboratories, and others. In 2022, hospitals and clinics represented the largest market share, but diagnostic laboratories are projected to grow the fastest in the upcoming years.
Key sources referenced in the preparation of this report on the endoscopy procedure market include the FDA (Food and Drug Administration), EUA (Emergency Use Authorization), EMA (European Medicines Agency), and EPA (Environmental Protection Agency).